CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 157 enrolled
Drug / intervention
Zicam (Ionic zinc) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00809809
NCT00809809Phase 3Completed
CompareCT.gov

A Randomized, Double-blind, Placebo-controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)

Integrative Medicine Institute·interventional·Posted Dec 17, 2008·Updated Jan 8, 2014

In Brief

A Phase 3 clinical trial evaluating Zicam (Ionic zinc) and placebo for Herpes Simplex Labialis. Completed, enrolled 157 participants across 3 sites.

Detailed Summary

Evaluate the effectiveness of a topical preparation of zinc to treat cold sores.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHerpes Simplex Labialis
CountriesUnited States
CollaboratorsWomen's Health Services, Santa Fe, New Mexico, Southwest College of Naturopathic Medicine, Beth Israel Medical Center, Matrixx Initiatives, Inc.

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 17, 2008
Enrollment StartDec 1, 2008
Primary CompletionSep 1, 2009
Study CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 17.5 years ago

Interventions

Zicam (Ionic zinc)drug

33mmol/l of ionic zinc

placebodrug

placebo swab